News Sentiment

301096 sentiment intelligence

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 2 relevant articles
Exchange SHZ China
Sector Healthcare Market context
Industry Drug Manufacturers - General Read-through group
Latest close 41.59 Week of 17 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings

58/100 classification confidence.

Company focus 2

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-18.0% over one week, -25.4% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Price to earnings forward of Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. Class A – SZSE:301096

Market Reaction

Price moving ahead of tone

50/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings 58/100 classification
One-week reaction -18.0% Price reacting lower
Trend fit Trend inactive -25.4% over four weeks
Fair value -21.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 2
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 2
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 1
BioWorld News 1

Event Lens

What the news is about

Classified themes
Earnings 1
Market update 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-2 of 2